CMYC expression in non-small cell lung cancer significantly correlated with PD-L1, and patients with CMYC+ and PD-L1+ tumour cells had a worse prognosis than other subgroups (p < 0.05) [14]. Here, CD274 is linked to non-small cell lung carcinoma.